Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
GermanyStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
GermanyStudy of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer
GermanySafety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema
GermanyStudy of ruxolitinib cream for treating hidradenitis suppurativa in adult patients
GermanyA study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer
GermanyStudy of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer
GermanyClinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments
GermanyStudy of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema
GermanyStudy on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
